The facility survey was conducted in 2008 and 2009 with support from the World Health Organization (WHO) This survey is a contribution to the baseline studies undertaken by MeTA which aim at providing a pharmaceutical sector assessment. The indicators in the survey measure the outcome and impact of strategic pharmaceutical programs in a country: improved access, quality and rational use. Access is measured in terms of the availability and affordability of essential medicines, especially to the poor and in the public sector. Measuring the actual quality of medicines by testing samples can be expensive. Instead, the presence of expired medicines on pharmacy shelves as well as the adequate handling and conservation conditions are indicators of the quality of medicines made available to the population. Availability of prices of innovator and generic medicines at the public procurement, public sector and private sector sources were studied in the survey. Finally, rational use is measured by examining the prescribing and dispensing habits of health providers and the implementation of key strategies such as standard treatment guidelines (STG) and essential medicines lists (EML).